This document discusses tubulointerstitial disorders, which are diseases affecting the renal tubules and interstitium. Tubulointerstitial disorders are distinguished from glomerular diseases by the absence of nephritic or nephrotic syndrome and the presence of tubular dysfunction manifesting as defects in concentration ability, polyuria, nocturia, and metabolic acidosis. Common tubulointerstitial disorders discussed include acute tubular necrosis, tubulointerstitial nephritis, pyelonephritis, drug-induced tubulointerstitial nephritis, analgesic nephropathy, and diseases causing hypercalcemia and nephrocalcinosis.
Membranous GN
MOST COMMON cause is idiopathic (85%); peak age 30-50; male:female, 2:1
May be secondary to:
Drugs-captopril, penicillamine, gold, mercury, trimethadione, NSAIDS
Infections-malaria (P. malariae), leprosy, schistosomiasis, syphilis, hepatitis B and C, filariasis, hydatid disease and enterococcal endocarditis
Diseases-malignancy (Carcinoma of breast, lung, colon, stomach, and esophagus) melanoma, renal cell CA, SLE, sarcoidosis, diabetes, thyroiditis, sickle cell anemia, Crohn’s disease
The document discusses various diseases of the kidney. It begins by describing the normal structure and functions of the kidney. It then discusses various glomerular and non-glomerular diseases in detail, including their classification, clinical manifestations, and microscopic pathology. Some of the diseases covered include glomerulonephritis, pyelonephritis, diabetic nephropathy, benign and malignant nephrosclerosis, and hydronephrosis.
This document discusses various pathologies of the kidney including congenital abnormalities, cystic diseases, glomerular diseases, tubular diseases, vascular diseases, and causes of obstruction. It provides descriptions of diseases such as polycystic kidney disease, glomerulonephritis, pyelonephritis, nephrosclerosis, and renal artery stenosis. Diagrams of kidney anatomy and histopathological images are also included.
This document provides an overview of renal pathology, including:
- The functions and anatomy of the kidney.
- Common renal diseases such as glomerular diseases (glomerulonephritis), tubular diseases (acute tubular necrosis), and vascular diseases (nephrosclerosis).
- Clinical syndromes like nephritic syndrome (hematuria, edema) and nephrotic syndrome (proteinuria, edema).
- Specific diseases are then described in more detail, including minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.
This document discusses various renal pathologies and syndromes. It describes how renal diseases can present as azotemia, prerenal azotemia, postrenal azotemia, or uremia. Major renal syndromes include acute nephritic syndrome, nephrotic syndrome, rapidly progressive glomerulonephritis, acute renal failure, and chronic renal failure. Specific glomerular diseases like minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy are also discussed in terms of their pathogenesis, morphology, and clinical course.
Glomerular diseases affect the glomerulus and can cause proteinuria, hematuria, and acute or chronic kidney damage. The glomerulus contains podocytes, endothelial cells, mesangial cells, and parietal epithelial cells surrounded by the glomerular basement membrane. Glomerular diseases present as nephrotic syndrome, acute or rapidly progressive nephritic syndrome, chronic glomerulonephritis, or asymptomatic urinary abnormalities. Pathologies include focal, diffuse, segmental, or proliferative lesions affecting the mesangium, basement membrane, or causing crescent formation.
Membranous GN
MOST COMMON cause is idiopathic (85%); peak age 30-50; male:female, 2:1
May be secondary to:
Drugs-captopril, penicillamine, gold, mercury, trimethadione, NSAIDS
Infections-malaria (P. malariae), leprosy, schistosomiasis, syphilis, hepatitis B and C, filariasis, hydatid disease and enterococcal endocarditis
Diseases-malignancy (Carcinoma of breast, lung, colon, stomach, and esophagus) melanoma, renal cell CA, SLE, sarcoidosis, diabetes, thyroiditis, sickle cell anemia, Crohn’s disease
The document discusses various diseases of the kidney. It begins by describing the normal structure and functions of the kidney. It then discusses various glomerular and non-glomerular diseases in detail, including their classification, clinical manifestations, and microscopic pathology. Some of the diseases covered include glomerulonephritis, pyelonephritis, diabetic nephropathy, benign and malignant nephrosclerosis, and hydronephrosis.
This document discusses various pathologies of the kidney including congenital abnormalities, cystic diseases, glomerular diseases, tubular diseases, vascular diseases, and causes of obstruction. It provides descriptions of diseases such as polycystic kidney disease, glomerulonephritis, pyelonephritis, nephrosclerosis, and renal artery stenosis. Diagrams of kidney anatomy and histopathological images are also included.
This document provides an overview of renal pathology, including:
- The functions and anatomy of the kidney.
- Common renal diseases such as glomerular diseases (glomerulonephritis), tubular diseases (acute tubular necrosis), and vascular diseases (nephrosclerosis).
- Clinical syndromes like nephritic syndrome (hematuria, edema) and nephrotic syndrome (proteinuria, edema).
- Specific diseases are then described in more detail, including minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.
This document discusses various renal pathologies and syndromes. It describes how renal diseases can present as azotemia, prerenal azotemia, postrenal azotemia, or uremia. Major renal syndromes include acute nephritic syndrome, nephrotic syndrome, rapidly progressive glomerulonephritis, acute renal failure, and chronic renal failure. Specific glomerular diseases like minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy are also discussed in terms of their pathogenesis, morphology, and clinical course.
Glomerular diseases affect the glomerulus and can cause proteinuria, hematuria, and acute or chronic kidney damage. The glomerulus contains podocytes, endothelial cells, mesangial cells, and parietal epithelial cells surrounded by the glomerular basement membrane. Glomerular diseases present as nephrotic syndrome, acute or rapidly progressive nephritic syndrome, chronic glomerulonephritis, or asymptomatic urinary abnormalities. Pathologies include focal, diffuse, segmental, or proliferative lesions affecting the mesangium, basement membrane, or causing crescent formation.
This document provides an overview of tubular diseases and pathologies of the kidney. It discusses acute tubular necrosis, tubulointerstitial nephritis including pyelonephritis, drug and toxin induced interstitial nephritis, urate nephropathy, hypercalcemia, multiple myeloma, and vascular diseases of the kidney. It describes the pathogenesis, clinical presentation, morphology, and factors involved in various acute and chronic kidney diseases that impact the tubules, interstitium, and blood vessels of the kidney.
Renal diseases in monoclonal gammopathies and cryoglobulinemiadrpallavip
Renal diseases in monoclonal gammopathies and cryoglobulinemia can present in various ways. Light chain deposition disease and amyloidosis are organized deposits where light chains or amyloid fibrils are deposited in the kidneys respectively. Acute tubular injury, inflammatory tubulointerstitial nephritis and light chain cast nephropathy are patterns of non-organized deposits that can occur. Cryoglobulinemic glomerulonephritis is caused by precipitation of monoclonal immunoglobulins in the glomerular capillaries at low temperatures. Biopsy with light microscopy, immunofluorescence and electron microscopy are required to identify the specific pattern of renal involvement and establish diagnosis.
This document discusses the clinical manifestations and pathophysiology of renal diseases. It begins by defining terms related to azotemia and renal failure. It then describes the major clinical syndromes seen in renal disease such as nephritic syndrome, nephrotic syndrome, asymptomatic urinary findings, rapidly progressive glomerulonephritis, acute renal failure and chronic renal failure. It further discusses the causes, presentations and pathophysiology of acute nephritic syndrome, nephrotic syndrome and glomerular injury from both immunological and non-immunological standpoints.
This document discusses tubular and tubulointerstitial diseases of the kidney. It begins by describing primary tubular diseases, which include acute tubular necrosis caused by ischemic or toxic injury. It then discusses tubulointerstitial diseases, which involve inflammatory involvement of the tubules and interstitium, such as pyelonephritis. Acute tubular necrosis is described as the most common cause of acute renal failure, characterized by sudden cessation of renal function. Features of ischemic versus toxic acute tubular necrosis are contrasted. Tubulointerstitial nephritis refers to inflammatory processes predominantly involving the renal interstitium. Specific diseases like acute and chronic pyelonephritis are then discussed in terms of
Glomerulonephritis refers to inflammation of the glomeruli in the kidney. It can be classified as either nephritic or nephrotic based on urine findings and the parts of the glomerulus affected. Nephritic glomerulonephritis presents with active urine sediment and involvement of endothelial cells and mesangial cells. Nephrotic glomerulonephritis presents with proteinuria, hyaline casts, and lipiduria with involvement of podocytes and the glomerular basement membrane. Minimal change disease is a common cause of nephrotic syndrome characterized by effacement and fusion of podocytes without inflammatory changes. Treatment involves corticosteroids with a high rate of remission
Renal pathology involves the study of the kidney and its structures. Glomerular injury can present as selective or non-selective proteinuria, nephrotic syndrome, hematuria, nephritic syndrome, or rapidly progressive glomerulonephritis. Nephrotic syndrome is characterized by heavy proteinuria, hypoproteinemia, edema, and hyperlipidemia. Nephritic syndrome presents with hematuria, proteinuria, oliguria, azotemia, and hypertension. Glomerulonephritis can result from immune complex deposition, antibody-mediated injury, cell-mediated immunity, or complement activation. Both immune and non-immune mechanisms can lead to glomerular damage.
This document provides an overview of glomerular diseases. It begins by describing the anatomy of the nephron and glomerulus. It then discusses the cells that make up the glomerular filtration membrane and defines glomerular diseases as abnormalities in glomerular function caused by damage to glomerular components like the epithelium, basement membrane, or endothelium. Primary and secondary glomerular diseases are distinguished. Immunological and non-immunological mechanisms of glomerular injury are also summarized. Specific glomerular diseases like membranoproliferative glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, IgA nep
This document outlines the objectives and content for two pathology lectures on renal glomerular syndromes including nephrotic syndrome and nephritic syndrome. The lectures will cover the clinical presentation and pathological findings of key renal diseases like minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, acute post-streptococcal glomerulonephritis, lupus nephritis, IgA nephropathy, and rapidly progressive glomerulonephritis. The lectures will discuss kidney biopsy techniques and the role of light microscopy, immunofluorescence and electron microscopy in the diagnosis of renal diseases. Key pathological mechanisms like the location of immune deposits and pathogenesis of glomerular
The kidneys filter waste and excess water from the blood to produce urine. Rapidly progressive glomerulonephritis (RPGN) is a severe form of glomerular injury characterized by the rapid loss of kidney function over weeks or months. It is classified based on the type of immune complex deposition, with Type I associated with anti-glomerular basement membrane antibodies, Type II associated with immune complexes, and Type III associated with few or no immune deposits but positive anti-neutrophil cytoplasmic antibodies. Histologically, RPGN is defined by the presence of crescents, which are areas of parietal epithelial cell proliferation that obliterate the Bowman's space.
Ischemic and toxic renal injury and renal disease in pregnancydrpallavip
1) The document discusses various renal pathologies seen in pregnancy and acute kidney injury. In preeclampsia, the kidneys show glomerular endotheliosis with endothelial swelling obstructing capillary lumens. Tubulointerstitial inflammation and vascular medial hypertrophy and hyalinosis are also seen.
2) Renal cortical necrosis appears as coagulative tubular and glomerular necrosis with preservation of architecture and polymorphonuclear infiltration. HELLP syndrome can cause acute tubular necrosis or cortical necrosis.
3) Other renal issues in pregnancy include urinary tract infections, renal disease exacerbation (IgA nephropathy), and postpartum hemolytic uremic syndrome with throm
The document discusses various types of glomerular and tubulointerstitial diseases:
1. Glomerular diseases are caused by damage to the glomerulus and can manifest as nephritic syndrome, nephrotic syndrome, or hematuria. Common glomerular diseases include minimal change disease, membranous nephropathy, and focal segmental glomerulosclerosis.
2. Tubulointerstitial diseases involve damage to the renal tubules and interstitium. Acute interstitial nephritis is often caused by drug reactions while chronic interstitial nephritis can result from various insults like drugs, infections, toxins, and inherited conditions.
3
This document discusses two types of nephrosclerosis: benign and malignant. Benign nephrosclerosis is caused by thickening of renal arterioles over time from aging, hypertension, or diabetes. It can cause scarring and loss of renal function. Malignant nephrosclerosis involves a worsening of hypertension that damages renal vessels, causing ischemia and sudden loss of function. The pathology involves fibrinoid necrosis and intimal thickening of arteries. Aggressive treatment of high blood pressure is needed to prevent permanent kidney damage in malignant nephrosclerosis.
This document discusses tubulo-interstitial pathology and chronic glomerulonephritis. It defines acute pyelonephritis, its causes and morphology. It describes chronic pyelonephritis and reflux nephropathy, including forms of chronic pyelonephritis and their gross and microscopic morphology. It also discusses drug-induced tubulo-interstitial nephritis, analgesic nephropathy, causes of chronic glomerulonephritis, and interpreting morphology of chronic glomerulonephritis.
The KIDNEY: SPECIFIC TYPES OF GLOMERULAR DISEASESDr. Roopam Jain
This document discusses different types of glomerular diseases. It provides details on acute post-streptococcal glomerulonephritis, including its etiology, pathogenesis, clinical features, and microscopic appearance. It also describes rapidly progressive glomerulonephritis, minimal change disease, and membranous glomerulonephritis, noting key distinguishing characteristics such as presentation, prognosis, and histopathological findings of each type. Comparative features of major forms of primary glomerulonephritis are analyzed.
This document discusses glomerular diseases and nephrotic syndrome. It begins by defining common pathological terms used to describe glomerular lesions, such as focal, diffuse, segmental, and proliferative. It then classifies glomerulopathies based on their clinical presentations, including nephrotic syndrome, acute glomerulonephritis, and rapidly progressive glomerulonephritis. Specific glomerular diseases are then discussed in more detail, with poststreptococcal glomerulonephritis and nephrotic syndrome getting the most attention. It provides information on pathogenesis, clinical features, investigations, prognosis, and treatment approaches for different glomerular diseases.
Renal pathology deals with diagnosing and characterizing kidney diseases through examination of renal biopsy specimens using light microscopy, electron microscopy, and immunofluorescence. The renal pathologist must synthesize findings across these diagnostic tools to reach a definitive diagnosis. Medical kidney diseases can affect the glomerulus, tubules and interstitium, blood vessels, or a combination of these renal compartments.
This document discusses various glomerular diseases. It begins with definitions of terms like acute renal failure, chronic renal failure, azotemia and uremia. It then describes different types of glomerular diseases like nephritic syndrome, nephrotic syndrome, acute proliferative glomerulonephritis, rapidly progressive glomerulonephritis and their characteristic features. The document contains detailed information on acute post-streptococcal glomerulonephritis including its etiology, morphology, clinical features and prognosis. Histopathological findings and classifications of various glomerular diseases are also summarized.
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASESDr. Roopam Jain
The document discusses glomerular diseases, which involve the renal glomeruli. It describes the classification of glomerular diseases into primary and secondary types. The major clinical manifestations are proteinuria, hematuria, hypertension, and impaired renal function. Six major glomerular syndromes are discussed: acute nephritic syndrome, nephrotic syndrome, acute renal failure, chronic renal failure, asymptomatic proteinuria, and asymptomatic hematuria. The pathogenesis of glomerular injury is examined by exploring the roles of endothelial, mesangial, epithelial and parietal cells as well as the glomerular basement membrane. Immunological and non-immunological mechanisms are involved in glomerular disease pathogenesis.
1 glomerular disease & anatomy pysiology of kidenyEngidaw Ambelu
This document provides an overview of kidney disease and glomerular diseases. It begins with the functions and anatomy of the kidney, focusing on the glomerulus and its role in filtration. It then discusses various glomerular diseases like nephrotic syndrome, nephritic syndrome, acute glomerulonephritis, and common causes like minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. Complications of nephrotic syndrome are also covered. The document provides detailed information on the pathology, clinical presentation, and treatment of different glomerular diseases.
Disease affecting tubules and interstitiumessamramdan
This document discusses disease affecting the renal tubules and interstitium. It begins by explaining that tubular injury often also involves the interstitium and can be inflammatory, as seen in interstitial nephritis, or ischemic, as seen in acute tubular necrosis. The document then goes on to describe various specific diseases in more detail, including tubulointerstitial nephritis of infectious and non-infectious origin, acute and chronic pyelonephritis, drug-induced interstitial nephritis, and analgesic nephropathy. It also provides morphological and clinical details of acute tubular necrosis.
Tubulointerstitial nephritis involves inflammatory reactions in the renal tubules and interstitium. It can be primary, secondary to other renal diseases, idiopathic, reactive to infections, or infectious itself. Acute tubular necrosis is characterized by tubular epithelial cell death due to ischemia or toxins and can cause acute kidney injury. Chronic tubulointerstitial nephritis develops over months or years and is associated with progressive loss of kidney function. It has many etiologies including drugs, infections, obstructive nephropathy, and autoimmune diseases.
The document discusses various kidney diseases, including primary and secondary glomerular diseases as well as tubular and tubulointerstitial diseases. It provides details on specific conditions like lupus nephritis, diabetic nephropathy, acute tubular necrosis, acute and chronic pyelonephritis, and tuberculous pyelonephritis. For each, it describes the pathogenesis, clinical features, morphologic findings, and complications. The document compares features of different forms of glomerulonephritis and contrasting features of ischemic versus toxic acute tubular necrosis. It includes diagrams to illustrate concepts like vesicoureteric reflux, obstructive pyelonephritis, and changes seen in
This document provides an overview of tubular diseases and pathologies of the kidney. It discusses acute tubular necrosis, tubulointerstitial nephritis including pyelonephritis, drug and toxin induced interstitial nephritis, urate nephropathy, hypercalcemia, multiple myeloma, and vascular diseases of the kidney. It describes the pathogenesis, clinical presentation, morphology, and factors involved in various acute and chronic kidney diseases that impact the tubules, interstitium, and blood vessels of the kidney.
Renal diseases in monoclonal gammopathies and cryoglobulinemiadrpallavip
Renal diseases in monoclonal gammopathies and cryoglobulinemia can present in various ways. Light chain deposition disease and amyloidosis are organized deposits where light chains or amyloid fibrils are deposited in the kidneys respectively. Acute tubular injury, inflammatory tubulointerstitial nephritis and light chain cast nephropathy are patterns of non-organized deposits that can occur. Cryoglobulinemic glomerulonephritis is caused by precipitation of monoclonal immunoglobulins in the glomerular capillaries at low temperatures. Biopsy with light microscopy, immunofluorescence and electron microscopy are required to identify the specific pattern of renal involvement and establish diagnosis.
This document discusses the clinical manifestations and pathophysiology of renal diseases. It begins by defining terms related to azotemia and renal failure. It then describes the major clinical syndromes seen in renal disease such as nephritic syndrome, nephrotic syndrome, asymptomatic urinary findings, rapidly progressive glomerulonephritis, acute renal failure and chronic renal failure. It further discusses the causes, presentations and pathophysiology of acute nephritic syndrome, nephrotic syndrome and glomerular injury from both immunological and non-immunological standpoints.
This document discusses tubular and tubulointerstitial diseases of the kidney. It begins by describing primary tubular diseases, which include acute tubular necrosis caused by ischemic or toxic injury. It then discusses tubulointerstitial diseases, which involve inflammatory involvement of the tubules and interstitium, such as pyelonephritis. Acute tubular necrosis is described as the most common cause of acute renal failure, characterized by sudden cessation of renal function. Features of ischemic versus toxic acute tubular necrosis are contrasted. Tubulointerstitial nephritis refers to inflammatory processes predominantly involving the renal interstitium. Specific diseases like acute and chronic pyelonephritis are then discussed in terms of
Glomerulonephritis refers to inflammation of the glomeruli in the kidney. It can be classified as either nephritic or nephrotic based on urine findings and the parts of the glomerulus affected. Nephritic glomerulonephritis presents with active urine sediment and involvement of endothelial cells and mesangial cells. Nephrotic glomerulonephritis presents with proteinuria, hyaline casts, and lipiduria with involvement of podocytes and the glomerular basement membrane. Minimal change disease is a common cause of nephrotic syndrome characterized by effacement and fusion of podocytes without inflammatory changes. Treatment involves corticosteroids with a high rate of remission
Renal pathology involves the study of the kidney and its structures. Glomerular injury can present as selective or non-selective proteinuria, nephrotic syndrome, hematuria, nephritic syndrome, or rapidly progressive glomerulonephritis. Nephrotic syndrome is characterized by heavy proteinuria, hypoproteinemia, edema, and hyperlipidemia. Nephritic syndrome presents with hematuria, proteinuria, oliguria, azotemia, and hypertension. Glomerulonephritis can result from immune complex deposition, antibody-mediated injury, cell-mediated immunity, or complement activation. Both immune and non-immune mechanisms can lead to glomerular damage.
This document provides an overview of glomerular diseases. It begins by describing the anatomy of the nephron and glomerulus. It then discusses the cells that make up the glomerular filtration membrane and defines glomerular diseases as abnormalities in glomerular function caused by damage to glomerular components like the epithelium, basement membrane, or endothelium. Primary and secondary glomerular diseases are distinguished. Immunological and non-immunological mechanisms of glomerular injury are also summarized. Specific glomerular diseases like membranoproliferative glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, IgA nep
This document outlines the objectives and content for two pathology lectures on renal glomerular syndromes including nephrotic syndrome and nephritic syndrome. The lectures will cover the clinical presentation and pathological findings of key renal diseases like minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, acute post-streptococcal glomerulonephritis, lupus nephritis, IgA nephropathy, and rapidly progressive glomerulonephritis. The lectures will discuss kidney biopsy techniques and the role of light microscopy, immunofluorescence and electron microscopy in the diagnosis of renal diseases. Key pathological mechanisms like the location of immune deposits and pathogenesis of glomerular
The kidneys filter waste and excess water from the blood to produce urine. Rapidly progressive glomerulonephritis (RPGN) is a severe form of glomerular injury characterized by the rapid loss of kidney function over weeks or months. It is classified based on the type of immune complex deposition, with Type I associated with anti-glomerular basement membrane antibodies, Type II associated with immune complexes, and Type III associated with few or no immune deposits but positive anti-neutrophil cytoplasmic antibodies. Histologically, RPGN is defined by the presence of crescents, which are areas of parietal epithelial cell proliferation that obliterate the Bowman's space.
Ischemic and toxic renal injury and renal disease in pregnancydrpallavip
1) The document discusses various renal pathologies seen in pregnancy and acute kidney injury. In preeclampsia, the kidneys show glomerular endotheliosis with endothelial swelling obstructing capillary lumens. Tubulointerstitial inflammation and vascular medial hypertrophy and hyalinosis are also seen.
2) Renal cortical necrosis appears as coagulative tubular and glomerular necrosis with preservation of architecture and polymorphonuclear infiltration. HELLP syndrome can cause acute tubular necrosis or cortical necrosis.
3) Other renal issues in pregnancy include urinary tract infections, renal disease exacerbation (IgA nephropathy), and postpartum hemolytic uremic syndrome with throm
The document discusses various types of glomerular and tubulointerstitial diseases:
1. Glomerular diseases are caused by damage to the glomerulus and can manifest as nephritic syndrome, nephrotic syndrome, or hematuria. Common glomerular diseases include minimal change disease, membranous nephropathy, and focal segmental glomerulosclerosis.
2. Tubulointerstitial diseases involve damage to the renal tubules and interstitium. Acute interstitial nephritis is often caused by drug reactions while chronic interstitial nephritis can result from various insults like drugs, infections, toxins, and inherited conditions.
3
This document discusses two types of nephrosclerosis: benign and malignant. Benign nephrosclerosis is caused by thickening of renal arterioles over time from aging, hypertension, or diabetes. It can cause scarring and loss of renal function. Malignant nephrosclerosis involves a worsening of hypertension that damages renal vessels, causing ischemia and sudden loss of function. The pathology involves fibrinoid necrosis and intimal thickening of arteries. Aggressive treatment of high blood pressure is needed to prevent permanent kidney damage in malignant nephrosclerosis.
This document discusses tubulo-interstitial pathology and chronic glomerulonephritis. It defines acute pyelonephritis, its causes and morphology. It describes chronic pyelonephritis and reflux nephropathy, including forms of chronic pyelonephritis and their gross and microscopic morphology. It also discusses drug-induced tubulo-interstitial nephritis, analgesic nephropathy, causes of chronic glomerulonephritis, and interpreting morphology of chronic glomerulonephritis.
The KIDNEY: SPECIFIC TYPES OF GLOMERULAR DISEASESDr. Roopam Jain
This document discusses different types of glomerular diseases. It provides details on acute post-streptococcal glomerulonephritis, including its etiology, pathogenesis, clinical features, and microscopic appearance. It also describes rapidly progressive glomerulonephritis, minimal change disease, and membranous glomerulonephritis, noting key distinguishing characteristics such as presentation, prognosis, and histopathological findings of each type. Comparative features of major forms of primary glomerulonephritis are analyzed.
This document discusses glomerular diseases and nephrotic syndrome. It begins by defining common pathological terms used to describe glomerular lesions, such as focal, diffuse, segmental, and proliferative. It then classifies glomerulopathies based on their clinical presentations, including nephrotic syndrome, acute glomerulonephritis, and rapidly progressive glomerulonephritis. Specific glomerular diseases are then discussed in more detail, with poststreptococcal glomerulonephritis and nephrotic syndrome getting the most attention. It provides information on pathogenesis, clinical features, investigations, prognosis, and treatment approaches for different glomerular diseases.
Renal pathology deals with diagnosing and characterizing kidney diseases through examination of renal biopsy specimens using light microscopy, electron microscopy, and immunofluorescence. The renal pathologist must synthesize findings across these diagnostic tools to reach a definitive diagnosis. Medical kidney diseases can affect the glomerulus, tubules and interstitium, blood vessels, or a combination of these renal compartments.
This document discusses various glomerular diseases. It begins with definitions of terms like acute renal failure, chronic renal failure, azotemia and uremia. It then describes different types of glomerular diseases like nephritic syndrome, nephrotic syndrome, acute proliferative glomerulonephritis, rapidly progressive glomerulonephritis and their characteristic features. The document contains detailed information on acute post-streptococcal glomerulonephritis including its etiology, morphology, clinical features and prognosis. Histopathological findings and classifications of various glomerular diseases are also summarized.
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASESDr. Roopam Jain
The document discusses glomerular diseases, which involve the renal glomeruli. It describes the classification of glomerular diseases into primary and secondary types. The major clinical manifestations are proteinuria, hematuria, hypertension, and impaired renal function. Six major glomerular syndromes are discussed: acute nephritic syndrome, nephrotic syndrome, acute renal failure, chronic renal failure, asymptomatic proteinuria, and asymptomatic hematuria. The pathogenesis of glomerular injury is examined by exploring the roles of endothelial, mesangial, epithelial and parietal cells as well as the glomerular basement membrane. Immunological and non-immunological mechanisms are involved in glomerular disease pathogenesis.
1 glomerular disease & anatomy pysiology of kidenyEngidaw Ambelu
This document provides an overview of kidney disease and glomerular diseases. It begins with the functions and anatomy of the kidney, focusing on the glomerulus and its role in filtration. It then discusses various glomerular diseases like nephrotic syndrome, nephritic syndrome, acute glomerulonephritis, and common causes like minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. Complications of nephrotic syndrome are also covered. The document provides detailed information on the pathology, clinical presentation, and treatment of different glomerular diseases.
Disease affecting tubules and interstitiumessamramdan
This document discusses disease affecting the renal tubules and interstitium. It begins by explaining that tubular injury often also involves the interstitium and can be inflammatory, as seen in interstitial nephritis, or ischemic, as seen in acute tubular necrosis. The document then goes on to describe various specific diseases in more detail, including tubulointerstitial nephritis of infectious and non-infectious origin, acute and chronic pyelonephritis, drug-induced interstitial nephritis, and analgesic nephropathy. It also provides morphological and clinical details of acute tubular necrosis.
Tubulointerstitial nephritis involves inflammatory reactions in the renal tubules and interstitium. It can be primary, secondary to other renal diseases, idiopathic, reactive to infections, or infectious itself. Acute tubular necrosis is characterized by tubular epithelial cell death due to ischemia or toxins and can cause acute kidney injury. Chronic tubulointerstitial nephritis develops over months or years and is associated with progressive loss of kidney function. It has many etiologies including drugs, infections, obstructive nephropathy, and autoimmune diseases.
The document discusses various kidney diseases, including primary and secondary glomerular diseases as well as tubular and tubulointerstitial diseases. It provides details on specific conditions like lupus nephritis, diabetic nephropathy, acute tubular necrosis, acute and chronic pyelonephritis, and tuberculous pyelonephritis. For each, it describes the pathogenesis, clinical features, morphologic findings, and complications. The document compares features of different forms of glomerulonephritis and contrasting features of ischemic versus toxic acute tubular necrosis. It includes diagrams to illustrate concepts like vesicoureteric reflux, obstructive pyelonephritis, and changes seen in
PATHOLOGY OF URINARY SYSTEM DISORDER pptSaili Gaude
This lecture includes pathology of renal calculi , renal carcinoma, bladder carcinoma, bladder tumor, renal tumor etc. This lecture have been prepared in view of Nursing students according to syllabus.
Chronic tubulointerstitial nephritis (CTIN) is characterized by tubular atrophy, interstitial fibrosis and inflammation. It can be caused by drugs like analgesics, lithium, and calcineurin inhibitors; heavy metals like lead and cadmium; or metabolic disorders like chronic uric acid nephropathy from long-term gout. Patients present with insidious kidney injury and progression to end-stage renal disease. Treatment focuses on discontinuing causative agents, supportive care, and controlling risk factors to slow disease progression.
tubulo-interstitial-nephropathy (1).pptlideta teka
This document discusses tubulointerstitial diseases, which involve inflammation and fibrosis of the renal tubules and interstitium. It describes two main types - acute and chronic tubulointerstitial nephritis. Causes include drugs, infections, autoimmune diseases, obstructive uropathy, and reflux nephropathy. Key histologic findings are interstitial inflammation, edema, and fibrosis with tubular injury and atrophy. Clinical features include renal dysfunction and tubular defects like aminoaciduria. Specific drug-induced forms like beta-lactam antibiotics and NSAIDs are outlined. Cystic diseases causing tubulointerstitial changes like PKD are also summarized.
The document summarizes renal functions, morphology, anatomy, urine formation, and clinical assessment of renal function. It describes the categories of acute renal failure as prerenal, intrinsic renal, or postrenal. Prerenal azotemia is caused by decreased effective blood volume or impaired renal blood flow and is reversible. Intrinsic renal azotemia directly involves the renal parenchyma, commonly from acute tubular necrosis or glomerulonephritis. Postrenal azotemia results from bilateral ureteric obstruction. Laboratory findings and urinalysis can help distinguish the three categories.
The Medical Assessment and Management of OliguriaLuis Daniel Lugo
The document discusses the medical assessment and management of oliguria. It defines oliguria as urine output less than 400 mL per day in adults. Oliguria can result from prerenal, intrinsic renal, or postrenal causes. The assessment of oliguria involves urine analysis and blood tests to evaluate electrolytes, BUN, creatinine, and acid-base balance. Medical management focuses on treating the underlying cause, managing fluid balance and hyperkalemia, and considering dialysis for complications like volume overload or refractory acidosis. Identifying and treating reversible causes is important for prognosis, which depends on etiology and comorbidities.
The document discusses common renal pathologies and their management in the perioperative period. It covers acute renal failure (ARF), chronic renal failure (CRF), diabetic nephropathy, nephrotic syndrome, glomerulonephritis, and pyelonephritis. ARF is classified as prerenal, intrinsic, or postrenal based on etiology. CRF results in fluid and electrolyte abnormalities, cardiac and pulmonary issues, and anemia. Diabetic nephropathy is caused by hypertension and hyperglycemia damaging the kidneys over time. Treatment focuses on controlling blood sugar and hypertension.
The document discusses acute renal failure (ARF), which refers to a sudden and usually reversible loss of renal function that develops over days or weeks. ARF can be pre-renal, intrinsic renal, or post-renal in cause. Reversible pre-renal ARF occurs when haemodynamic disturbances like hypotension produce acute dysfunction that can be rapidly reversed by treating the underlying cause and restoring renal perfusion. Left untreated, pre-renal ARF can progress to established acute tubular necrosis. Proper diagnosis involves assessing the cause, signs of poor perfusion, and urine and blood tests. Management focuses on correcting the underlying problem and restoring blood volume through fluids.
This document provides an overview of acute kidney injury (AKI). It defines AKI and notes its worldwide epidemiology. The main causes of AKI are discussed as pre-renal, renal, and post-renal. The pathophysiology of each type is explained. Clinical presentation depends on the cause but may include elevated creatinine and reduced urine output. Staging of AKI is outlined using KDIGO criteria. Investigations and management aim to identify and treat the underlying cause while maintaining fluid and electrolyte balance. Complications include fluid overload and metabolic disturbances. Prognosis depends on severity and comorbidities.
Renal insufficiency occurs when the kidneys fail to remove waste and regulate fluids and electrolytes. It can be acute or chronic. Acute renal failure involves a rapid decline in function and is classified as prerenal, intrarenal, or postrenal based on cause. Chronic renal failure is a progressive loss of kidney function that eventually leads to death without treatment. It involves stages of initial damage, polyuria, oliguria, and terminal kidney failure. Treatment for chronic renal failure includes dialysis or kidney transplantation.
Common presentation and investigation of Kidney diseasesEzmeer Emiral
This document provides an overview of the common presentations, investigations, and features of major renal diseases. It discusses the normal functions of the kidney and outlines typical symptoms of renal disease like dysuria, polyuria, oliguria, and hematuria. Specific conditions covered include glomerulonephritis, urinary tract infections, renal failure, polycystic kidney disease, and urinary tract obstruction. Investigations involve urine analysis, blood tests, imaging, and renal biopsy. Features, causes, and clinical presentations of various renal conditions are described in detail.
Chronic renal failure refers to the irreversible deterioration of renal function over years. It initially presents as biochemical abnormalities and eventually leads to uraemic symptoms as the excretory, metabolic and endocrine functions of the kidneys fail. Common causes include diabetes, hypertension, and glomerulonephritis. Management involves identifying and treating the underlying disease, slowing progression, managing complications, and renal replacement therapy for end-stage disease.
Chronic renal failure is an irreversible deterioration in renal function that develops over years. It initially only causes biochemical abnormalities but eventually leads to uraemia and loss of kidney excretory, metabolic and endocrine functions. The most common causes are diabetes, hypertension, and glomerulonephritis. As kidney function declines, patients experience widespread effects including anaemia, acidosis, cardiovascular disease, bone disease, muscle problems, neuropathy, endocrine abnormalities, bleeding issues, and increased susceptibility to infection.
This document discusses tubular and interstitial diseases, focusing on acute kidney injury (AKI) and acute tubular necrosis (ATN). It provides details on:
1) The pathogenesis of AKI involving tubular cell injury from ischemia or toxins, disturbances in blood flow causing vasoconstriction, and the repair process through growth factors and cytokines.
2) The morphology of ischemic AKI, seen as focal tubular necrosis and casts, and the morphology of toxic AKI varying by toxin but often involving necrosis.
3) The clinical course of AKI proceeding through initiation, maintenance, and recovery phases and sometimes being nonoliguric. Prognosis depends on the cause,
The document provides an overview of urinary system semiotics and urine syndrome. It discusses the main symptoms of kidney and urinary tract diseases, which include pain, edema, dysuria, arterial hypertension, and renal failure. It then examines each of these symptoms in more detail. For example, it describes the different types of pain seen in diseases like nephrolithiasis and pyelonephritis. It also outlines disorders of urination like polyuria, oliguria, and dysuria. The document concludes by presenting the case of a 52-year-old male patient complaining of fever, back pain, delayed urination, and morning edema, who has a medical history of similar symptoms for several years.
1. Renal failure can be acute or chronic and is classified based on the underlying cause and pathology. Acute renal failure (ARF) is characterized by a rapid decline in renal function and accumulation of waste products in the blood. Common causes of ARF include decreased blood flow to the kidneys, direct kidney damage, or urinary tract obstruction.
2. Chronic renal failure (CRF) is an irreversible deterioration of renal function that develops slowly over time. It can be caused by diseases affecting the glomeruli or tubulointerstitial tissues. CRF results in fluid and electrolyte imbalances as well as metabolic abnormalities that manifest as uraemic symptoms.
3. Laboratory findings in renal
This document discusses renal failure, including acute kidney injury (AKI) and chronic renal failure. It defines AKI as the sudden loss of kidney function over hours to days, causing a buildup of waste products. AKI can be caused by decreased blood flow, direct kidney damage, or obstruction of urine flow. The stages of AKI are initiation, oliguria, diuresis, and recovery. Treatment involves fluid management, electrolyte control, infection prevention, and possibly dialysis. Nursing care focuses on monitoring fluids and electrolytes, reducing the metabolic rate, providing skin care, and preventing infections.
Anti diabetic medications
Patients who are intolerant of metformin are unlikely to be successful with a third trial of that agent. Empagliflozin, an SGLT2 inhibitor, is considered a second-line choice for patients who are intolerant of metformin. Both sitagliptin, a DPP-4 inhibitor, and liraglutide, a GLP-1 receptor agonist, should be avoided or used with caution in patients with a history of pancreatitis
-Linagliptin is not cleared by the kidney second choice if GFR<35(Stop Metformin)
only liraglutide has been shown to lower the risk of recurrent cardiovascular events and has received FDA approval for this indication
Empagliflozin, an SGLT2 inhibitor, has also been associated with secondary prevention of cardiovascular disease.
Fasting C-peptide levels are markedly elevated in patients with T2DM, but in people with T1DM, C-peptide levels should be low
. TZDs tend to cause fluid retention and should not be used in patients with congestive heart failure
References
ADA
Step up to medicine
Toronto notes
UpToDate
ABFM
The key features in this case are:
- Age of 4 years old
- Abdominal mass
- Hematuria
- Hypertension
This combination of findings is classic for Wilms tumor (nephroblastoma), which is the most common renal tumor in children.
The diagnosis is Wilms tumor (D).
1. Women aged 21-24 with ASC-US or LSIL should have repeat cytology in 1 year; if negative twice, return to routine screening, but AGC, HSIL or ASC-H requires colposcopy.
2. Women over 30 should have co-testing every 5 years; if HPV negative the risk is low, but a positive HPV requires repeat co-testing in 1 year or colposcopy if cytology is ASC-US or greater.
3. ASC-H in women over 25 requires colposcopy regardless of HPV results due to possibility of significant abnormality.
Normal Heart
Fist size muscular pump
Pumps 6000 lit of blood daily
Perfuses
tissues with nutrients and
Facilitates
removal of waste products.
Heart diseases
Have severe physiologic consequences
Are leading cause of morbidity and mortality in developed nations
750,000 deaths/ year (In US
This document describes various congenital heart diseases (CHD) including their embryology, classification, pathophysiology and clinical presentations. It discusses abnormalities causing left-to-right shunts such as ventricular septal defects, atrial septal defects and patent ductus arteriosus which can cause volume overload. It also describes right-to-left shunting defects like tetralogy of Fallot and transposition of the great arteries which result in cyanosis. Obstructive lesions including coarctation of the aorta are also summarized. Fetal circulation is compared to changes at birth.
Infective Endocarditis(IE)
Is due to bacterial or fungal infection of the heart valves (endocardium).
Characterized by:
Formation of bulky, friable,easily detached and infected vegetations.
Damage to heart Valves and Chorda tendinae
perforation, ulceration, destruction (causes valve dysfunction)
Ischemic Heart Disease
IHD is caused by myocardial ischemia due to
Imbalance between the myocardial oxygen demand and supply from the coronary arteries.
Majority of cases due to
Reduction in coronary artery blood flow caused by
Obstructive atherosclerotic disease.
IHD is also known as Coronary artery disease
The document discusses several disorders of the pleura and lungs, including pleural effusions, pneumothorax, and mesothelioma. Pleural effusions can be transudative or exudative depending on disturbances to Starling forces or increased vessel permeability. Pneumothorax can be spontaneous due to bleb rupture or tension pneumothorax from a flap-like pleural tear. Mesothelioma is a malignant tumor of the pleura associated with asbestos exposure that encases the lung.
Restrictive lung diseases (interstitial lung diseases)
Histological Structure of Alveoli
The wall of the alveoli is formed by a thin sheet of tissue separating two neighbouring alveoli.
This sheet is formed by epithelial cells and intervening connective tissue.
Collagenous , reticular and elastic fibres are present.
Between the connective tissue fibres we find a dense, anastomosing network of pulmonary capillaries. The wall of the capillaries are in direct contact with the epithelial lining of the alveoli.
Neighbouring alveoli may be connected to each other by small alveolar pores (pores of Kohn).
The epithelium of the alveoli is formed by two cell types:
Alveolar type I cells (small alveolar cells or type I pneumocytes) are extremely flattened and form the bulk (95%) of the surface of the alveolar walls.
Alveolar type II cells (large alveolar cells or type II pneumocytes) are irregularly (sometimes cuboidal) shaped.
They form small bulges on the alveolar walls.
Type II alveolar cells contain are large number of granules called cytosomes (or multilamellar bodies), which consist of precursors to pulmonary surfactant (the mixture of phospholipids which keep surface tension in the alveoli low) .
Cilia are absent from the alveolar epithelium and cannot help to remove particulate matter which continuously enters the alveoli with the inspired air. Alveolar macrophages take care of this job. They migrate freely over the alveolar epithelium and ingest particulate matter.
FUNCTIONS OF PULMONARY CELLS
Type I pneumocytes
Permeable to Oxygen and CO2, do not divide
Type II pneumocytes
Reserve cells
secrete pulmonary surfactant
Serve as repair cells
Alveolar macrophages
Phagocytosis
Pores of Kohn (allow passage of Macrophages)
Asthma
A chronic relapsing inflammatory disorder characterized by:
Hyper-reactivity of the respiratory tree to various stimuli leading to
Reversible airway obstruction
Obstruction produced by combination of :
Constriction of bronchial musculature (bronchospasm)
Mucosal inflammation (edema)
Excessive secretion of mucus.
Clinically Manifested by :
Difficulty in breathing (Dyspnea)
Wheeze (a soft whistling sound during expiration)
Difficulty in expiration.
Asthma is:
Episodic and reversible airway disease
Primarily targets the bronchi and terminal bronchioles
MC chronic respiratory disease in children
Two types:
Extrinsic asthma (allergic, atopic)
Intrinsic asthma (non-allergic asthma or idiosyncratic asthma)
Obstructive diseases : Chr.by
Obstruction to airflow out of the lungs
Due to partial or complete obstruction in airway.
Increase in lung compliance and
Decrease in lung elasticity.
Restrictive diseases : Chr by
reduced expansion of lung parenchyma with problems in getting air in the lungs.
Lung compliance is decreased
Elasticity is increased: once air is in the lungs it comes out rapidly on expiration.
Tumors of lung
Malignant tumors of lung
Primary
Metastatic
Metastatic lung cancer
More common* than primary lung cancer.
Breast cancer (MCC)
Renal Cell carcinoma
Choriocarcinomas
Colorectal carcinomas
Appear as: "Cannon Balls” On X rays
This document discusses several types of pneumonia including nosocomial, aspiration, and lung abscess pneumonia. It provides details on causative organisms, pathophysiology, clinical features, diagnosis and treatment. Key points include:
- Nosocomial pneumonia is associated with immunosuppression, antibiotics, and respirators. Common organisms are E. coli, Pseudomonas aeruginosa, and S. aureus.
- Aspiration pneumonia results from gastric content aspiration and is characterized by necrotizing inflammation. Causative organisms include a mixture of oral aerobes and anaerobes like Bacteroides and S. pneumoniae.
- Lung abscesses develop most commonly from aspiration or
1. Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by diffuse alveolar capillary damage and severe pulmonary edema, resulting in hypoxemia that is refractory to oxygen therapy.
2. ARDS is caused by direct or indirect injury to the lungs from sources such as sepsis, gastric aspiration, trauma, or smoke inhalation. This causes damage to the alveolar capillary endothelium and epithelium.
3. The damage leads to increased capillary permeability, leakage of fluid into the alveoli, and formation of hyaline membranes. This results in impaired gas exchange and respiratory failure.
Heavy Metal poisoning
Lead, Arsenic, and Mercury
Produce acute or chronic intoxications
Blood tests are most useful for screening for heavy metal poisoning
Environmental diseases can be caused by chemical, physical, or biological agents. Tobacco use is a major cause of preventable death and disease worldwide. Smoking causes lung cancer, COPD, cardiovascular disease, and many other cancers. Secondhand smoke also increases disease risk. Alcohol abuse commonly causes liver disease, cancers, neurological disorders like Wernicke's encephalosis, and fetal alcohol syndrome. Indoor air pollutants like carbon monoxide from fires or malfunctioning heaters can cause hypoxia and death at high levels. Many therapeutic drugs and recreational drugs can also cause adverse environmental diseases if misused or abused.
This document discusses functional vascular disorders and Raynaud's phenomenon. It describes Raynaud's phenomenon as intermittent attacks of ischemia to the fingers, toes, ears or nose due to spasms of small arteries. Raynaud's phenomenon is classified as either idiopathic/Raynaud's disease which occurs alone in young healthy women, or secondary Raynaud's which occurs with connective tissue diseases. Hypertension is also discussed, including types, pathophysiology involving the kidneys and renin-angiotensin system, complications such as heart and brain damage, and malignant hypertension.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...Donc Test
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
1. Disease affecting the tubules
and Interstitium
Most disorders affecting tubules
also involve interstitium – grouped
as tubulo-interstitial disorders
2. Clinically, How are TI disorders
distinguished from glomerular
diseases?
• Early course – Absence of nephritic or nephrotic
syndrome
• Presence of Defects in tubular function
(concentration ability)
• Polyuria, nocturia, salt wasting, disturbance in
secretion of acid (metabolic acidosis)
• Late course : difficult to distinguish from
glomerular diseases
4. Acute renal failure
• Acute suppression of renal function and
urine flow <400ml /24 hrs
• Causes : Pre-renal, intra-renal & Post
renal
• Most common cause is Acute tubular
necrosis
5. What is ATN?
• Clinico-pathologic entity characterized
morphologically by destruction of tubular
epithelial cells and clinically by ARF.
• It is important to recognize because by
early management, this condition is
reversible.
• 2 major causes – Ischemia & Toxins
6.
7. Pathogenesis of ATN
• Tubular cell injury
Reversible Irreversible
Loss of polarity & detachment
Distal Na delivery Obstruction by casts Necrosis
Apoptosis
Vasoconstriction Reduced tubular flow
Reduced GFR ----------Oliguria
10. Morphology – Ischemic type ATN
– Focal tubular necrosis at multiple points
along the entire nephron (with long skip
areas)
– History of recent hemorrhage, hypotension,
surgery
– Urinalysis: Muddy (dirty)brown granular or
tubular epithelial cells casts
12. Ischemic tubular necrosis
• Tubules in acute tubular necrosis are dilated and lined by atrophic
epithelium. Some contain characteristic pigment casts
13. Morphology – Nephrotoxic type
ATN
– Produces predominantly proximal tubule
damage (No skip segments) with sparing of
the distal tubules and basement membranes
– Mercury – Injured cells contain acidophilic
inclusions later calcify
– Ccl4 –accumulation of lipids with necrosis
– Ethylene glycol – Ca oxylate crystals in lumen
– Better prognosis than Ischemic Type
15. ATN - Ethylene glycol
• Ca Oxalate crystals in tubular lumen by
polarizing microscopy
16. ATN – Clinical course
– Initiation phase: (upto 36) Grossly the kidneys
are swollen and edematous.
– Slight decline in urine output & raise in BUN
– Maintenance phase: After 1-2 weeks, Urine
output the lowest(40-400ml/day) , electrolyte
imbalances, hyperkalemia & uremic
manifestations.
– Recovery phase: Tubular regeneration
occurs with normal renal function returning
after tubular cells mature (after three weeks).
Initially, there is polyuria until the tubular
cells mature
– Often there is hypokalemia
21. Acute Pyelonephritis
• Suppurative bacterial infection (E. coli most
common organism)- grossly focal discrete
abscess in 1 or both kidneys
• Microscopically – Neutrophilic infiltration of
interstitium & tubules
• Clinical: most patients are young women
between the ages of 15 and 40 years
22. Acute Pyelonephritis
• Sudden onset of costovertebral angle
tenderness, fever, chills, nausea and vomiting,
and lower urinary tract signs of dysuria and
frequency of urination
• Laboratory-urinalysis
– Bacteriuria, WBCs (Pyuria), WBC casts (key finding –
casts are formed only in tubules)
• Complications: chronic pyelonephritis,
Pyonephrosis, perinephric abscess, papillary
necrosis, septicemia and endotoxin shock
23. Acute PN
• In the lower pole of this
kidney is a 1 cm pale
yellow abscess
25. Renal papillary necrosis
• Notice the pale
grey zones in the
papillae
surrounded by an
hyperemic zone.
These are actually
regions of
necrosis, so-
called renal
papillary necrosis.
• Seen in diabetics
and Acute PN
26. Chronic Pyelonephritis
• Progression of acute pyelonephritis
• 2 types:
• Reflux type is most common and relates to VUR
beginning in childhood
• Obstructive type due to obstruction in lower urinary tract
with infection
These result in large scarred areas of the kidney and distortion of
the pyramids
Clinical presentation may be silent, gradual onset renal
insufficiency, hypertension
Late stages – Present with proteinuria due to FSGS and end stage
renal failure
• Diagnosis: IVP-flattening of the calyces underlying
cortical scars
27. • Hall mark lesion: U-shaped Cortico-
medullary scar overlying a blunted, dilated,
deformed calyx
28. Chronic Pyelonephritis
• The typical large
“geographic “
scarring and the
distortion of the
pyramids is seen
here.(Asymmetric
scarring seen
here, Contrast
with CGN, which
is symmetric)
30. Chronic PN
• Hallmark micro feature:Thyroidization (colloid casts
in tubules) is typical of chronic pyelonephritis. This
will result in broad casts in the urine sediment.
31. Xanthogranulomatous
pyelonephritis
• Form of C. pyelonephritis
• Gross – large yellowish nodules
• Accumulation of foamy macrophages and
giant cells
• Associated with Proteus infection
32. Acute Drug-Induced Tubulointerstitial
Nephritis (hypersensitivity nephritis)
• Acute onset (approx. 15 days after drug exposure-
although most patients require several weeks of drug
exposure before developing renal injury) of azotemia,
oliguria, fever, EOSINOPHILIA , rash, mild to
moderate proteinuria, and hematuria on occasion
• Frequently occurs with synthetic antibiotics Ex-
Methicillin, Ampicillin
• An immunologic reaction involving type I or type IV
hypersensitivity
• Eosinophils in the urine are a good marker of a drug-
induced hypersensitivity reaction
• Renal failure occurs in 50% of patients
• Biopsy – Edema, infiltration of eosinophils and
inflammatory cells in interstitium. Sometimes
granuloma and giant cells can be seen
34. Analgesic Abuse Nephropathy
• Form of renal disease with intake of analgesic
mixtures presenting with chronic tubulo-
interstitial nephritis and renal papillary necrosis
• analgesic abuse - (aspirin + Phenacetin or
acetaminophen)
• Acetaminophen is the metabolite of
phenacetin that causes injury to cells by
forming free radicals;
• Aspirin inhibits prostaglandin synthesis and
when combined with acetaminophen, normal
vasodilatation effects of prostaglandins are
inhibited producing ischemic injury to the
renal papillae
35. Analgesic Abuse Nephropathy
• Papillary necrosis occurs first followed by
tubulointerstitial nephritis
• All papillae are affected but in different stages of
necrosis (contrast with diabetes where all
papillae are same stage of necrosis) with
dystrophic calcification, sloughing
• Micro – necrosis of papillae, In cortex- atrophy of
tubules, inflammation and fibrosis
36. Analgesic Abuse Nephropathy
• Clinical course:
• Common in women
• Early course: concentrating ability is lost
(Polyuria) later chronic renal insufficiency
• Anemia – due to phenacetin metabolites toxic to
RBCs
• Urine- Hematuria when there is sloughing of
papillae
• Renal colic – Obstruction by papillae
• Long term complication – Transitional cell
carcinoma of the renal pelvis
39. Urate Nephropathy
• Uric acid nephropathy can produce three
lesions.
• acute uric acid nephropathy –Chemotherapy
• Chronic urate nephropathy – Gout
• Nephrolithiasis – Uric acid stones
40. Urate Nephropathy
• Note the typical finely fibrillar appearance of the uric
acid crystals with adjacent fibrosis and the atrophy
of the renal parenchyma.
41. Hypercalcemia & Nephrocalcinosis
• Causes : Hyperparathyroidism, multiple
myeloma, Vit D intoxication, metastatic
bone disease, milk-alkali syndrome
• Deposition of calcium in the tubular
basement membranes(metastatic
calcification)
• Results in polyuria due to a lack of
concentrating ability
42. Multiple Myeloma
• Cast Nephropathy: Bence-Jones proteins
combine with the urinary glycoprotein
(Tamm-Horsfall) under acidic conditions to
form large, histologically distinct tubular
casts that obstruct the tubular lumina and
induce granulomatous inflammation
• Amyloidosis
• Hypercalcemia & Hyperuricemia
46. Kidney Complications in
Hypertension
• Benign Nephrosclerosis : Sclerosis of
renal arterioles and small arteries
• Pathogenesis : Medial and intimal
thickening (hemodynamic response)
• Hyaline deposition in arterioles
(Extravasation of plasma proteins)
• Clinically- mild reduction in GFR with mild
proteinuria
47. Benign Nephrosclerosis - Gross
• Size –normal or
reduced
• Surface has fine
granularity resembling
the grains of a leather
as shown in picture
49. Malignant Nephrosclerosis
• Renal disease in accelerated phase of
hypertension (malignant HT)
• Pathogenesis : Related to damage to
vessels by long standing benign HT with
increased permeability to proteins,
endothelial injury and platelet deposition
• Leading to fibrinoid necrosis and
intravascular thrombosis
50. Malignant Nephrosclerosis
• Gross : ‘Flea-
bitten’ kidney –
small petechial
hemorrhages on
cortical surface
due to rupture of
arterioles and
capillaries
51. Malignant Nephrosclerosis
• Micro 1 –
Fibrinoid
necrosis of a
small vessel
with pink
fibrin in the
walls
• This feature
also called
Necrotizing
arteriolitis
52. Malignant Nephrosclerosis
Micro 2 –
Hyperplastic
arteriolitis -
Thickening and
proliferation of
smooth muscle cells
of the arterial wall
and collagen
producing an "onion
skin"appearance.
This finding is more
often seen than
fibrinoid necrosis
53. Renal artery stenosis(RAS)
• Important to recognize because HT can be
surgically cured
• Two types
– Occlusion by atheromatous plaque (older men)
– Fibromuscular hyperplasia (young females)
Pathogenesis – Hypertension result from abnormal
activity of the renin-angiotensin system in the
chronically ischemic kidney
57. Thrombotic Microangiopathies
• Group of disorder with thrombosis of capillaries and
arterioles thru out the body characterized clinically by
MAHA, thrombocytopenia and renal failure. Termed as
HUS/TTP syndrome
• HUS – renal symptoms predominate
• TTP – CNS symptoms predominate
• Classification :
• Classic childhood HUS
• Adult HUS – Infection, Anti-phospholipid antibodies,
pregnancy, Vascular disorders
• Idiopathic HUS/TTP
• Pathogenesis : Vascular obstruction and constriction
related to endothelial injury(toxin mediated) and platelet
aggregation
58. Classic (Childhood) HUS syndrome
• Main cause for renal failure in children
• Intestinal infection of Verocytotoxin producing E.coli
(type O157:H7) or shiga toxin of Shigella infection
• Epidemics – Intake of infected hamburger (ground meat)
• Clinical – Diarrhea, oliguria, hematuria and MAHA,
Hypertension, ARF
• Peripheral blood smear- MAHA with schistocytes &
thromocytopenia
• Kidney – Widespread cortical necrosis
• Micro – arterioles show fibrinoid necrosis and
Subendothelial deposits of fibrin in vessel walls &
occlusion by platelet thrombi
59. Thrombotic Microangiopathy
• In this case of Hemolytic-Uremic syndrome note
the platelet-fibrin thrombi in the glomerular
capillaries.
60. Diffuse Cortical Necrosis
• Cortical necrosis which is bilateral and
symmetrical
• ischemic in origin and arises from
conditions that result in disseminated
intravascular coagulation.
• Ex- Abruptio placentae - premature
separation of the placenta, hemolytic–
uremic syndrome and septic shock.
64. Renal Infarction
• Renal infarcts MOST COMMONLY
develop from thromboemboli/vegetations
originating in the left heart
• Less common causes are vasculitis, sickle
cell disease
• Patients present with flank pain, fever,
leukocytosis, proteinuria, and hematuria
• Infarcts are anemic or pale, wedge-
shaped(base towards cortex)
65. Renal Infarct
• Gross – Pale, wedge
shaped infarct
• Micro – Normal area in
the Rt and infarcted area
with coagulative necrosis
on Lt
67. Hydronephrosis
• Term used to describe dilatation of renal
pelvis and calyces with atrophy of the
kidney due to obstruction to flow of urine
• C/F depends on Uni or Bilaterality and
partial or complete obstruction
- Partial obstruction – Polyuria
- Complete - Anuria
• Investigations – IVP & USG